Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array

Pediatric Blood and Cancer

Volumn 52, Issue 7, 2009, Pages 777-783

  Kamimatsuse, Arata ^a   Matsuura, Kaoru ^b   Moriya, Shogo ^b   Fukuba, Ikuko ^a,c   Yamaoka, Hiroaki ^d   Fukuda, Emi ^a,c   Kamei, Naomi ^a   Hiyama, Keiko ^c   Sueda, Taijiro ^a   Hiyama, Eiso ^a,c,d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Nisshinbo Industries Incorporated   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Caspase 8; Methylation; Microarray; Neuroblastoma; Oligoarray; Promoter

Indexed keywords

CASPASE 8; DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEUROBLASTOMA; NEWBORN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CASPASE 8; CHILD; CHILD, PRESCHOOL; CPG ISLANDS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INFANT; INFANT, NEWBORN; INTRONS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 67650478320     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21977     Document Type: Article

References (24)

1. Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 2002;184:127-147.
2. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-216. (Pubitemid 37328872)
3. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet 2000;16:168-174. (Pubitemid 30169152)
4. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407: 770-776.
5. Fulda S, Debatin KM. Apoptosis pathways in neuroblastoma therapy. Cancer Lett 2003;197:131-135.
6. Wolf BB, Green DR. Suicidal tendencies: Apoptotic cell death by caspase family proteinases. J Biol Chem 1999;274:20049-20052. (Pubitemid 129519463)
7. Steller H. Artificial death switches: Induction of apoptosis by chemically induced caspase multimerization. Proc Natl Acad Sci USA 1998;95:5421-5422. (Pubitemid 28224107)
8. Kim HS, Lee JW, Soung YH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125:708-715. (Pubitemid 37070689)
9. Ebinger M, Senf L, Wachowski O, et al. Promoter methylation pattern of caspase-8, P16INK4A,MGMT, TIMP-3, and E-cadherin in medulloblastoma. Pathol Oncol Res 2004;10:17-21. (Pubitemid 38506607)
10. Teitz T,Wei T,Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000;6:529-535. (Pubitemid 30305902)
11. Banelli B, Gelvi I, Di Vinci A, et al. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene 2005;24:5619-5628. (Pubitemid 43119355)
12. Moriya S, Urawa S, Suzuki O, et al. DNA microarray for rapid detection of mitochondrial DNA haplotypes of chum salmon. Mar Biotechnol (NY) 2004;6:430-434. (Pubitemid 40580409)
13. Shimada H, Umehara S, Monobe Y, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer 2001;92:2451-2461. (Pubitemid 33029092)
14. Esteller M, Fraga MF, Paz MF, et al. Cancer epigenetics and methylation. Science 2002;297:1807-1808; discussion 1807-1808.
15. Ricci-Vitiani L, Pedini F, Mollinari C, et al. Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J Exp Med 2004;200:1257-1266. (Pubitemid 39552567)
16. Hiyama E, Iehara T, Sugimoto T, et al. Effectiveness of screening for neuroblastoma at 6 months of age: A retrospective population-based cohort study. Lancet 2008;371:1173-1180.
17. Iolascon A, Borriello A, Giordani L, et al. Caspase 3 and 8 deficiency in human neuroblastoma. Cancer Genet Cytogenet 2003;146:41-47.
18. Banelli B, Casciano I, Croce M, et al. Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region. Nat Med 2002;8:1333-1335; author reply 1335. (Pubitemid 36019400)
19. Casciano I, Banelli B, Croce M, et al. Caspase-8 gene expression in neuroblastoma. Ann NYAcad Sci 2004;1028:157-167.
20. Harada K, Toyooka S, Shivapurkar N, et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002;62:5897-5901. (Pubitemid 35204751)
21. Clark SJ. Action at a distance: Epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007; 16:R88-R95. (Pubitemid 47241847)
22. Yang Q, Kiernan CM, Tian Y, et al. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res 2007;13:3191-3197.
23. Margetts CD, Astuti D, Gentle DC, et al. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19, and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer 2005;12:161-172. (Pubitemid 40477096)
24. Hatada I, Fukasawa M, Kimura M, et al. Genome-wide profiling of promoter methylation in human. Oncogene 2006;25:3059-3064. (Pubitemid 43780470)